Neurosense Therapeutics Ltd (NRSN)

$0.91 -$0.10 (-9.81%) 4:38 PM 12/11/24
NASDAQ | $USD | Biotechnology

Stock Data

  • Market Cap

    $21.54M

  • Day's Range

    $0.88 - $0.98

  • Volume

    308,514

  • 52 Week Low / High

    $0.51 - $2.33

  • PE Ratio

    -

  • PEG Ratio

    -

  • Dividend Frequency

    -

NRSN's Dividend
-
Amount
-
Dividend Yield
-
Payment Date
-
Annual Dividend Amount
Dividend Streak
Hypothetical 10k Investment Jan 1, 2020
Capital Growth
Dividend Return to Date
Dividend Payout year Est.
Expenses
Total Return
Total Return %
Analyists Ranking
1
Strong Buy
1
Buy
0
Hold
0
Sell
0
Strong Sell
$7.25
Target Price

Company News

  • NeuroSense Announces First Quarter 2024 Business Update — May 2nd, 2024

    CAMBRIDGE, Mass., May 2, 2024 /PRNewswire/ -- NeuroSense Therapeutics Ltd. (Nasdaq: NRSN) ("NeuroSense"), a company developing novel treatments for severe neurodegenerative diseases, today provides a business update. NeuroSense Therapeutics Logo Corporate Highlights from Q1 2024 and To D...

Similar Stocks

No similar stocks found.

Want to be notified on dividend changes?

Start manging your portfolio today.

Sign up for free